DB22/T 396.6-2017 Active Jilin ProvinceLocal standards

DB22/T 396.6-2017 Healthcare product toxicological evaluation procedures and testing methods - Part 6: Bacterial reverse mutation test

Publish Date: 2017-11-10 Implement Date: 2017-12-30 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Basic Information

Standard Code: DB22/T 396.6-2017

Standard Type: Local standards

Standard Status: Active

is_force_gb: no

CCS Name: Basic standards and general methods

ICS Name: Integrated medical science and healthcare devices

Publish Date: 2017-11-10

Implement Date: 2017-12-30

Pages: 9 pages

Development Information

Pages: 9 pages

Same series standard

DB22/T 396.1-2017 DB22/T 396.2-2017 Healthcare product toxicological evaluation procedures and testing methods - Part 2: Acute transdermal toxicity test DB22/T 396.3-2017 Healthcare product toxicological evaluation procedures and testing methods - Part 3: Long-term transdermal toxicity test DB22/T 396.4-2017 Healthcare product toxicological evaluation procedures and testing methods - Part 4: Skin irritation test DB22/T 396.5-2017 Healthcare product toxicological evaluation procedures and testing methods - Part 5: Skin allergic reaction test DB22/T 396.7-2017 DB22/T 396.7-2017 Toxicological Evaluation Procedures and Test Methods for Healthcare Products - Part 7: Microchromosome Nucleosome Test for Rodents DB22/T 396.8-2017 Healthcare products toxicological evaluation procedures and testing methods - Part 8: Mouse sperm morphology test DB22/T 396.9-2017 Toxicological Evaluation Program and Test Methods for Healthcare Products - Part 9: Mammalian Cell Chromosome Aberration Test DB22/T 396.10-2017 Healthcare product toxicological evaluation procedures and testing methods - Part 10: Teratogenicity testing. (Note: This is a placeholder translation and the final English translation may differ.) DB22/T 396.11-2017 Toxicological Evaluation Procedure and Test Methods for Healthcare Products - Part 11: Carcinogenicity Test DB22/T 396.12-2017 Healthcare product toxicological evaluation procedures and testing methods - Part 12: Skin patch test in humans

Replace the following standards

DB22/T 396-2014 Healthcare product toxicological evaluation procedures and testing methods

Related Standards

GB 3232-1982 Abolished

GB 3232-1982 Diagnostic criteria and principles of management of occupational chronic manganism

Publish Date: 1982-10-25

GB 3233-1982 Abolished

GB 3233-1982 Diagnostic criteria and principles of management of occupational chronic carbon disulfide poisoning

Publish Date: 1982-10-25

GB 3234-1982 Abolished

GB 3234-1982 Diagnostic criteria and principles of management of industrial fluorosis

Publish Date: 1982-10-25

GB 4865-1985 Abolished

GB 4865-1985 Diagnostic criteria and principles of management of occupational chronic allyl chloride poisoning

Publish Date: 1985-01-14

GB 4869-1985 Abolished

GB 4869-1985 Diagnostic criteria and principles of management of occupational vibration disease

Publish Date: 1985-01-14

GB 5044-1985 Abolished

GB 5044-1985 Classification of health hazard levels from occupational exposure to toxic substances

Publish Date: 1985-04-02